Covid-19 Investigational Treatment Trial

Description

Seeking men and women who have been hospitalized with the coronavirus COVID-19 for a study of an experimental drug.

Overview

We are studying whether the experimental drug can be safely used and if it improves people's health when they are sick with the COVID-19 coronavirus. The experimental treatment has been studied in animals and in people, but has not been studied for use yet in people who have COVID-19. Half of the people in this trial will get the experimental drug and half will get a drug that looks like the experimental drug but has no active medicine.

What we're hoping for

We hope that the experimental drug is safe for use and helps people hospitalized with the COVID-19 coronavirus recover.

UMMS University Campus

About

Support

Resources

The UMass Center for Clinical and Translational Science is part of the
Clinical and Translational Science Award (CTSA) program, funded by the
National Center for Advancing Translational Sciences (Grant #
UL1-TR001453) at the National Institutes of Health (NIH).
NIH Citation Requirements

This is an
official Page of
the University of Massachusetts Medical School